Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sechtem, U.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sechtem, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Imaging myocardial area at risk and final infarct size

U. Sechtem1

Department for Cardiology and Pulmology, Centre for Internal Medicine, Robert Bosch Hospital, Stuttgart, Germany

1 Correspondence: Professor Dr Udo Sechtem, Abteilung für Kardiologie and Pulmologie, Zentrum fur Innere Medizin, Robert-Bosch-Krankenhaus, Auerbachstrasse 110, 70376 Stuttgart, Germany

References

  1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349–360[Medline]
  2. Wilcox RG, von der Lippe G, Olsson CG, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988;ii:525–530
  3. Kennedy JW, Martin GV, Davis KB, et al. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. Circulation. 1988;77:345–352[Abstract/Free Full Text]
  4. Khaja F, Walton JA, Brymer IF, et al. Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med. 1983;308:1305–1311[Abstract]
  5. Ritchie JL, Davis KB, Williams DL, Caldwell J, Kennedy JW. Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase In Myocardial Infarction Trial. Circulation. 1984;70:867–875[Abstract/Free Full Text]
  6. Guerci AD, Gerstenblith G, Brinker JA, et al. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987;317:1613–1618[Abstract]
  7. Hatori N, Tadokoro H, Satomura K, et al. Beneficial effects of coronary venous retroinfasion but not left atrial administration of superoxide dismutase on myocardial necrosis in pigs. Eur Heart J. 1991;12:442–450[Abstract/Free Full Text]
  8. Segawa D, Sjoquist PO, Wang QD, et al. Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine. J Cardiovasc Pharmacol. 2000;36:338–343[CrossRef][Web of Science][Medline]
  9. Shimizu M, Sjoquist PO, Wang QD, Ryden L. Effects of the angiotensin ATl receptor blocker candesartan on myocardial ischemic/reperfusion injury. J Am Soc Nephrol. 1999;10(Suppl 11):S137–S142
  10. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation. 1990;82:1424–1437[Abstract/Free Full Text]
  11. Hearse DJ. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res. 2000;45:213–219[Web of Science][Medline]
  12. Lee IT, Ideker RE, Reimer KA. Myocardial infarct size and location in relation to the coronary vascular bed at risk in man. Circulation. 1981;64:526–534[Abstract/Free Full Text]
  13. Lowe JE, Reimer KA, Jennings RB. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol. 1978;90:363–379[Abstract]
  14. Feiring AL, Johnson MR, Kioschos JM, et al. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation. 1987;75:980–987[Abstract/Free Full Text]
  15. Li QS, Frank TL, Franceschi D, Wagner HN, Becker LC. Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs. J Nucl Med. 1988;29:1539–1548[Abstract/Free Full Text]
  16. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol. 1988;12:1573–1581[Abstract]
  17. Gibbons RJ. Perfusion imaging with 99mTc-sestamibi for the assessment of myocardial area at risk and the efficacy of acute treatment in myocardial infarction. Circulation. 1991;84:137–142
  18. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropylisonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation. 1989;80:1277–1286[Abstract/Free Full Text]
  19. Schömig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/111a blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med. 2000;343:385–391[Abstract/Free Full Text]
  20. Eisner RL, Schmarkey LS, Martin SE, et al. Defects on SPECT ‘perfusion’ images can occur due to abnormal segmental contraction. J Nucl Med. 1994;35:638–643[Abstract/Free Full Text]
  21. Sinusas AL, Shi Q, Vitols PJ, et al. Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size. Circulation. 1993;88:2224–2234[Abstract/Free Full Text]
  22. Kemper AL, O'Boyle JE, Cohen CA, Taylor A, Parisi AF. Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Circulation. 1984;70:309–317[Abstract/Free Full Text]
  23. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage. Circulation. 1993;88:2596–2606[Abstract/Free Full Text]
  24. Cobb FR, Bache RJ, Rivas F, Greenfield JC. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest. 1976;57:1359–1368
  25. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation. 1993;88:596–604[Abstract/Free Full Text]
  26. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699–1705[Abstract/Free Full Text]
  27. Kloner RA, Ganote CE, Jennings RB. The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496–1508
  28. Kaul S, Kelly P, Oliner JD, et al. Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol. 1989;13:468–482[Abstract]
  29. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223–228[Abstract/Free Full Text]
  30. Sabia PL, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992;327:1825–1831[Abstract]
  31. Firschke C, Lindner JR, Wei K, et al. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second generation echocardiographic contrast agent. Circulation. 1997;96:959–967
  32. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol. 1995;26:1340–1347[Abstract]
  33. Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation. 2000;101:2368–2374[Abstract/Free Full Text]
  34. van Rugge FP, van der Wall EE, van Dijkman PR, et al. Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol. 1992;70:1233–1237[CrossRef][Web of Science][Medline]
  35. Sandstede JJ, Lipke C, Beer M, et al. Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. Am J Roentgenol. 2000;174:1737–1740[Abstract/Free Full Text]
  36. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379–1383[Abstract/Free Full Text]
  37. Schussheim AE, Kwong RY, London JF, et al. MRI can triage low and medium risk patients with chest pain: prospective evaluation of cardiac magnetic resonance imaging in the emergency room (Abstr). Circulation. 2000;102(Suppl II):II–488
  38. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002[Abstract/Free Full Text]
  39. Lima JA, Judd RM, Bazille A, et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation. 1995;92:1117–1125[Abstract/Free Full Text]
  40. Schaefer S, Malloy CR, Katz J, et al. Gadolinium-DTPA enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol. 1988;12:1064–1072[Abstract]
  41. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med. 1996;36:684–693[Web of Science][Medline]
  42. Pereira RS, Prato FS, Lekx KS, Sykes J, Wisenberg G. Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion. Magn Reson Med. 2000;44:309–316[CrossRef][Web of Science][Medline]
  43. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94:3318–3326[Abstract/Free Full Text]
  44. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453[Abstract/Free Full Text]
  45. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 1998;98:1006–1014[Abstract/Free Full Text]
  46. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–772[Abstract/Free Full Text]
  47. Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298–1304[Abstract/Free Full Text]
  48. Gibbons RJ, Miller TD, Christian TF. Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction. Circulation. 2000;101:101–108[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sechtem, U.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sechtem, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?